Healthcare -
Biotechnology - NASDAQ - US
$ 1.345
-15.4 %
$ 86.8 M
Market Cap
-0.78
P/E
INZY - REVENUE
Revenue INZY - Inozyme Pharma, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR